{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "https://eldaddp.azurewebsites.net/answeredquestions.text?creator.label=Biography+information+for+Mark+Pritchard", "definition" : "https://eldaddp.azurewebsites.net/meta/answeredquestions.text?creator.label=Biography+information+for+Mark+Pritchard", "extendedMetadataVersion" : "https://eldaddp.azurewebsites.net/answeredquestions.text?_metadata=all&creator.label=Biography+information+for+Mark+Pritchard", "first" : "https://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&creator.label=Biography+information+for+Mark+Pritchard", "hasPart" : "https://eldaddp.azurewebsites.net/answeredquestions.text?creator.label=Biography+information+for+Mark+Pritchard", "isPartOf" : "https://eldaddp.azurewebsites.net/answeredquestions.text?creator.label=Biography+information+for+Mark+Pritchard", "items" : [{"_about" : "http://data.parliament.uk/resources/1723767", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1723767/answer", "answerText" : {"_value" : "
NHS England is delivering a range of interventions that are expected to improve early diagnosis and treatment for patients with suspected and diagnosed pancreatic cancer. For early diagnosis, this includes providing a route into pancreatic cancer surveillance for those patients at inherited high-risk, to identify lesions before they develop into cancer, and diagnose cancers sooner. New pathways are being created to support faster referral routes for people with non-specific symptoms that could be linked to a range of cancer types. General practice direct access to diagnostic tests is also being increased.<\/p>
To improve the consistency of access to treatments, NHS England is funding an audit into pancreatic cancer which aims to stimulate improvements in cancer treatment and outcomes. The Royal College of Surgeons began work on this audit in October 2022, and the first report is expected in October 2024.<\/p>
NHS England\u2019s Getting it Right First Time programme has also appointed a team of five specialist clinicians to lead a national review into services for pancreatic cancer patients in England. The\u202fworkstream\u202fsupports the delivery of the Optimal Care Pathway, a Pancreatic Cancer UK-led initiative which has brought together 300 health professionals and people affected to agree on how standards of diagnosis, treatment, and care of those patients with pancreatic cancer and their families can be improved, as well as gathering examples of good practice to share.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1506", "label" : {"_value" : "Biography information for Andrew Gwynne"} } , "answeringMemberConstituency" : {"_value" : "Gorton and Denton"} , "answeringMemberPrinted" : {"_value" : "Andrew Gwynne"} , "dateOfAnswer" : {"_value" : "2024-08-01", "_datatype" : "dateTime"} , "groupedQuestionUIN" : {"_value" : "2022"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2024-08-01T09:01:19.977Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2024-07-26", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Pancreatic Cancer: Health Services"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps he is taking to improve the early (a) diagnosis and (b) treatment of pancreatic cancer.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1576", "label" : {"_value" : "Biography information for Mark Pritchard"} } , "tablingMemberConstituency" : {"_value" : "The Wrekin"} , "tablingMemberPrinted" : [{"_value" : "Mark Pritchard"} ], "uin" : "1908"} , {"_about" : "http://data.parliament.uk/resources/1723768", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1723768/answer", "answerText" : {"_value" : "
The Department has been working with suppliers to address current supply issues with pancreatic enzyme replacement therapy (PERT), including Creon, used in the treatment of cystic fibrosis and certain cancers, including pancreatic cancer. The supply issues are impacting countries throughout Europe, and have been caused by the limited availability of raw ingredients and manufacturing capacity constraints in producing the volumes needed to meet demand. The Department is continuing to work with all suppliers of PERT to help resolve the supply issues in the short and longer term. This includes asking that they expedite deliveries, source stock from other markets, and increase production.<\/p>
We have issued comprehensive guidance to healthcare professionals about these supply issues, which provides advice on how to manage patients whilst there is disruption to supply. This guidance is being kept under review, and updates will be made as necessary. Serious Shortage Protocols are in place for\u202fCreon\u202f10,000 and 25,000 capsules to limit prescriptions to one months\u2019 supply, to allow demand management.<\/p>
We understand how frustrating and distressing medicine supply issues can be. While we can\u2019t always prevent supply issues from occurring, the Department has a range of well-established processes and tools to manage them when they arise, and to help mitigate risks to patients.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4444", "label" : {"_value" : "Biography information for Karin Smyth"} } , "answeringMemberConstituency" : {"_value" : "Bristol South"} , "answeringMemberPrinted" : {"_value" : "Karin Smyth"} , "dateOfAnswer" : {"_value" : "2024-08-05", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2024-08-05T09:42:23.303Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2024-07-26", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Pancreatic Enzyme Replacement Therapy"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure adequate supplies of pancreatic enzyme replacement therapy medication.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1576", "label" : {"_value" : "Biography information for Mark Pritchard"} } , "tablingMemberConstituency" : {"_value" : "The Wrekin"} , "tablingMemberPrinted" : [{"_value" : "Mark Pritchard"} ], "uin" : "1909"} , {"_about" : "http://data.parliament.uk/resources/1723769", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1723769/answer", "answerText" : {"_value" : "
NHS England is establishing over 550 new neonatal nurse posts across England, including in the Shropshire, Telford and Wrekin Integrated Care System (ICS), since publishing Implementing the Recommendations of the Neonatal Critical Care Transformation Review, which is available at the following link:<\/p>